<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08904121810727</udiDi>
    <basicUdiDi>B-08904121810727</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5040</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:18:53.123Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810710</udiDi>
    <basicUdiDi>B-08904121810710</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0040</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:18:51.931Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810703</udiDi>
    <basicUdiDi>B-08904121810703</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5040</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:18:50.719Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810697</udiDi>
    <basicUdiDi>B-08904121810697</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0040</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:18:49.523Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810680</udiDi>
    <basicUdiDi>B-08904121810680</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7540</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:18:43.523Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810673</udiDi>
    <basicUdiDi>B-08904121810673</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5040</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:18:42.432Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810666</udiDi>
    <basicUdiDi>B-08904121810666</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2540</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:18:39.920Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121808045</udiDi>
    <basicUdiDi>B-08904121808045</basicUdiDi>
    <tradeName>genXSync Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>genXSync Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC2.1 2.7508</reference>
    <placedOnMarketCountry>Luxembourg</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:18:38.721Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810659</udiDi>
    <basicUdiDi>B-08904121810659</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0040</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:27.411Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810642</udiDi>
    <basicUdiDi>B-08904121810642</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5037</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:26.195Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810635</udiDi>
    <basicUdiDi>B-08904121810635</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0037</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:23.800Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810628</udiDi>
    <basicUdiDi>B-08904121810628</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5037</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:20.195Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810611</udiDi>
    <basicUdiDi>B-08904121810611</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0037</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:17.789Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810604</udiDi>
    <basicUdiDi>B-08904121810604</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7537</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:16.586Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810598</udiDi>
    <basicUdiDi>B-08904121810598</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5037</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:14.209Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810581</udiDi>
    <basicUdiDi>B-08904121810581</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2537</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:10.588Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810574</udiDi>
    <basicUdiDi>B-08904121810574</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0037</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:08.205Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810567</udiDi>
    <basicUdiDi>B-08904121810567</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5032</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:06.978Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810550</udiDi>
    <basicUdiDi>B-08904121810550</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0032</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:03.381Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810543</udiDi>
    <basicUdiDi>B-08904121810543</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5032</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:17:00.978Z</lastUpdated>
  </row>
</eudamedExport>